Surgical Ovulation Induction in Women with Polycystic Ovary Syndrome: A Systematic Review
Authors
Abstract:
Background: Currently clomiphene citrate is the first-line treatment to induce ovulation in women with polycystic ovarian syndrome (PCOS). Surgical therapy with laparoscopic ovarian drilling (LOD) may avoid or reduce the need for gonadotropins. Objective: To determine the effectiveness and safety of LOD compared with ovulation induction in subfertile women with clomiphene-resistant PCOS. Search Strategy: A systematic search was performed on PubMed (1966 to August 2007), the Ovid database (1966 to August 2007), and EMBASE (1974-2007). The search terms included: infertility, menstrual disorder, hirsutism, PCOS, surgical intervention, electrocautery, electrocoagulation, diathermy, drilling, and laparoscopic ovarian drilling, ovulation, pregnancy rate, post operation adhesions and ovarian blood flow. Selection Criteria: Randomized controlled trials of women with clomiphene-resistant PCOS who were treated with LOD to induce ovulation were included. Data Collection and Analysis: 3141 patients from 35 trials preformed in different geographic settings were included. All trials were assessed for quality criteria. We included those trials which followed hormonal changes, ovulation, and pregnancy rates after LOD. The primary outcomes measured were hormonal changes, ovulation, and pregnancy rates as well as ovarian artery blood flow, and the secondary outcome was rate of pelvic organ adhesion. Main Results: The overall ovulation rate after LOD was 79.2% (74.9%-83.5% 95% CI). Of all women who ovulated only 66.6% (60.8%-72.4% 95% CI) conceived. The mean peri-adnexal adhesion rate was 22.7% (21.4%-24% 95% CI). Conclusion: Compared with medical therapy, LOD has many advantages including: to be done once, no need for intensive monitoring, no chance of multiple pregnancy or ovarian hyperstimulation syndrome. LOD effectively decreases ovarian androgens and improves folliculogenesis and increases chance of ovulation and pregnancy rate. Finally, in vitro fertilisation should be considered as the last resort.
similar resources
surgical ovulation induction in women with polycystic ovary syndrome: a systematic review
background: currently clomiphene citrate is the first-line treatment to induce ovulation in women with polycystic ovarian syndrome (pcos). surgical therapy with laparoscopic ovarian drilling (lod) may avoid or reduce the need for gonadotropins. objective: to determine the effectiveness and safety of lod compared with ovulation induction in subfertile women with clomiphene-resistant pcos. se...
full textP-62: Extended Letrozole Therapy for Ovulation Induction in Women with Polycystic Ovary Syndrome
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in young women which has different clinical consequences. This study was conducted to evaluate the outcome of long or extended letrozole therapy for induction of ovulation in patients with polycystic ovary syndrome (PCOS). Materials and Methods: This prospective controlled study was conducted in a university hospital on...
full textGreen Tea Supplement in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Background: Polycystic ovary syndrome (PCOS) is a common metabolic disorder among age reproductive women. It could result in anovulation, infertility insulin resistance, and obesity. Dietary intake especially antioxidant components may improve some disorders. The current study is the first meta-analysis to assess the effect of green tea, a source of antioxidants, on anthropometric and insulin a...
full textOvulation induction in polycystic ovary syndrome.
Management of polycystic ovary syndrome (PCOS) usually spans a woman's reproductive years. While treatment of androgenic symptoms is often a primary concern, periodically, the regimen has to be modified because of a desire for pregnancy. As these women are usually anovulatory, ovulation induction is generally required. The premise on which ovulation induction in PCOS is based is two-fold: incre...
full textThe use of insulin sensitising agents in ovulation induction in women with polycystic ovary syndrome.
Insulin resistance is an important "upstream" driver for reproductive and metabolic abnormalities in women with Polycystic Ovary Syndrome (PCOS). This theoretical background is now supported by substantial evidence for treating women with PCOS with insulin sensitising agents such as metformin or the thiazolidinediones. Although the available data are based upon studies comprised of relatively s...
full textSOGC Clinical Practice Guideline Ovulation Induction in Polycystic Ovary Syndrome
Objective: To review current non-pharmacologic and pharmacologic options for ovulation induction in women with polycystic ovary syndrome (PCOS). Options: This guideline reviews the evidence for the various options for ovulation induction in PCOS. Outcomes: Ovulation, pregnancy and live birth rates, risks, and side effects are the outcomes of interest. Evidence: Published literature was retrieve...
full textMy Resources
Journal title
volume 34 issue 4
pages 225- 241
publication date 2009-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023